Please check your internet connection and try again.
# Lorazepam (representative benzodiazepine)
## Overview
Lorazepam is a benzodiazepine with anxiolytic, sedative, hypnotic, amnestic, anticonvulsant, and muscle relaxant properties. It is metabolized by glucuronidation, making it a good choice in patients with hepatic impairment compared to other benzodiazepines metabolized by the cytochrome P450 system.
## Primary Indications
* Anxiety disorders
* Insomnia associated with anxiety
* Seizures (status epilepticus)
* Pre-anesthetic medication
* Sedation in intensive care settings
## Adult Dosing
* **Anxiety:** 1-3 mg orally every 8-12 hours. Maximum: 10 mg per day.
* **Insomnia:** 2-4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg IV initially. May repeat doses every 5-10 minutes up to a maximum of 8 mg in a 12-hour period. IV administration should be slow (1-5 mg/min) and monitored closely.
* **Pre-anesthetic:** 2-3 mg IM or IV one hour prior to surgery.
* **ICU Sedation:** Initial dose of 1-4 mg IV, followed by 0.5-10 mg per hour infusions as needed. Titration is key. Dosing for ICU sedation often depends on clinical assessment and local protocols.
## Pediatric Dosing
Dosing in pediatric patients is highly variable and should be guided by specific diagnosis, age, weight, and clinical response. There is less established trial data for precise pediatric dosing compared to adults.
* **Status Epilepticus:** 0.1 mg/kg IV, up to a maximum of 4 mg per dose. May repeat in 5-10 minutes.
* **Sedation/Anxiety:** Oral and IV doses are generally lower than adult doses and require careful titration. Specific pediatric guidelines or protocols should be consulted.
## Dose Adjustments
* **Hepatic Impairment:** No dose adjustment is typically needed due to glucuronidation metabolism.
* **Renal Impairment:** No dose adjustment is typically needed.
## Contraindications
* Known hypersensitivity to lorazepam or other benzodiazepines.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency.
* Severe hepatic insufficiency (use with caution).
* Myasthenia gravis (use with caution).
* Sleep apnea.
## Adverse Effects
* **Common:** Sedation, dizziness, weakness, ataxia, confusion.
* **Less Common:** Paradoxical excitement, amnesia, respiratory depression (especially with IV administration or in combination with other CNS depressants), hypotension, gastrointestinal upset.
## Key Drug Interactions
* **CNS Depressants (e.g., opioids, alcohol, other sedatives):** Potentiates CNS depression, leading to increased sedation, respiratory depression, coma, and death. Use with extreme caution and consider dose reduction of one or both agents.
* **Valproic acid:** May increase lorazepam plasma concentrations.
* **Theophylline/Aminophylline:** May antagonize the sedative effects of lorazepam.
## Monitoring
* Respiratory rate, heart rate, blood pressure, and oxygen saturation, especially with IV administration or in at-risk patients.
* Level of sedation and cognitive function.
* Signs of withdrawal if used chronically and then discontinued.
## Clinical Pearls
* Lorazepam's intramuscular absorption is generally reliable.
* IV lorazepam can cause respiratory depression and hypotension; administer slowly and monitor closely.
* Consider the risk of dependence and withdrawal with prolonged use. Tapering of dose is recommended upon discontinuation.
* Avoid concomitant use with other CNS depressants if possible.
***
*This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant guidelines for complete details.*
